Patient safety is paramount within the life sciences market. Companies need to ensure pharmacovigilance practices effectively identify product issues as early as possible in the product life cycle. Our clients utilize adverse event reporting and pharmacovigilance systems to meet regulatory submission requirements, identify potential safety problems, and to manage risk. Our team has the experience in supporting implementation of and upgrades to these systems, including Clintrace, ARISg, Argus, and PV Works.